- TWD5.84bn
- TWD5.02bn
- TWD1.26bn
- 74
- 51
- 71
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,381 | 1,157 | 1,246 | 1,319 | 1,264 |
Cost of Revenue | |||||
Gross Profit | 549 | 532 | 584 | 615 | 604 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,334 | 1,094 | 1,078 | 1,161 | 1,129 |
Operating Profit | 46.7 | 63.1 | 168 | 158 | 135 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.9 | 172 | 199 | 207 | 330 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22.8 | 161 | 179 | 114 | 293 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20 | 159 | 177 | 107 | 287 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 20 | 159 | 177 | 107 | 287 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.266 | 1.35 | 1.79 | 1.18 | 3.18 |
Dividends per Share | |||||
Special Dividends per Share |